Eyestem Raises Series A Round to Develop a Cure for Rare Eye Ailment
Eyestem, a Bengaluru-based cell therapy startup, has raised $6.4 million in a Series A round led by three pharma majors, Biological E. Limited (BE), Alkem, NATCO, and Kemwell Biopharma promoters...
Read more